Effect of Macugen (Pegaptanib) on surgical outcomes and growth factors including vascular endothelial growth factor (VEGF) levels in patients with proliferative diabetic retinopathy (PDR) and clinically significant diabetic macular edoema (CSDME). Here, VEGFA is linked to proliferative diabetic retinopathy.